Yunfeng, Co-Win Leads $32M Series B In Huakang Mobile Health

Login to View

Shenzhen-based Huakang Mobile Health has completed RMB200 million (US$32 million) series B round of financing from Yunfeng Capital, Shenzhen Co-Win Venture Capital Investments Limited, New Horizon Capital, and Henan Haijie Healthcare Investment, according to Chinese media reports.

The revelation of the new funding round follows the announcement last week that Huakang has established a strategic partnership with Ali Health, Alibaba Group Holding’s subsidiary focusing on healthcare services.

Continue reading with a China Money Network subscription

Join Now

Already have an account or paid subscription? Log in